Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

N-acetylglucosamine reduces multiple inflammation and neurodegeneration markers in MS patients

UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and neurodegeneration markers in people who suffer from multiple sclerosis (MS).

14 Sep 2023

People who require specialized neurologic care most often travel long distances, study finds

Nearly one in five people on Medicare travel 50 or more miles one way to see a neurologist, a doctor who diagnoses and treats diseases of the brain and nervous system, according to research published in the September 13, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Sep 2023

“Inverse vaccine” shows promise to reverse autoimmune diseases without shutting down rest of the immune system

A new type of vaccine developed by researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis, type 1 diabetes, and Crohn's disease -; all without shutting down the rest of the immune system.

12 Sep 2023

Scientists develop new method to detect key fat-filled particles in the brain

Scientists have created a method to detect key fat-filled particles known as lipoproteins in the central nervous system, opening a new view into the workings of the brain.

12 Sep 2023

NIH grants support Kessler Foundation scientists to advance research on neglect dyslexia and autism

Three Kessler Foundation research scientists, Timothy Rich, PhD, OTR/L, and Co-Principal Investigators Helen Genova, PhD, and Heba Elsayed, MD, have been awarded $777,325 in federal grants by the National Institutes of Health (NIH) to expand research in the fields of neglect dyslexia and autism.0

11 Sep 2023

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a publication, “Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer’s disease”, in the preeminent journal, Proceedings of the National Academy of Sciences (PNAS), that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD), a difficult-to-treat neuroinflammatory disease.

9 Sep 2023

Convincing evidence supports avoidance of cannabis during adolescence, pregnancy and while driving

Experts recommend avoiding cannabis during adolescence and early adulthood, in people prone to or with mental health disorders, in pregnancy, and before and while driving, based on an in-depth evidence review published by The BMJ today.

7 Sep 2023

People with traumatic brain injuries in earlier life may be at increased risk of late life cognitive decline

A study of twins shows that having a concussion early in life is tied to having lower scores on tests of thinking and memory skills decades later as well as having more rapid decline in those scores than twins who did not have a concussion, or traumatic brain injury (TBI).

7 Sep 2023

Could medicinal plants be the key to reversing cognitive decline?

Researchers explore available evidence that medicinal plants may help improve cognitive function by reducing brain inflammation.

5 Sep 2023

AI-driven analysis of MRI scans could pave the way for improved multiple sclerosis treatment

New research exploring cutting-edge Artificial Intelligence (AI) technology to better analyse MRI scans of patients with multiple sclerosis (MS) could unlock crucial insights into disease progression and pave the way for improved treatment of people living with the condition.

4 Sep 2023

Scientists reclassify 200 rare immune system disorders using network-based approach

Scientists at CeMM, Max Perutz Labs, and St. Anna Children's Cancer Research Institute in Vienna have achieved a significant advancement in the research of rare immune system disorders.

1 Sep 2023

When temps rise, so do medical risks. Should doctors and nurses talk more about heat?

An important email appeared in the inboxes of a small group of health care workers north of Boston as this summer started. It warned that local temperatures were rising into the 80s.

1 Sep 2023

Statins may lower risk of ischemic stroke after hemorrhagic stroke

People who have had a stroke called an intracerebral hemorrhage who take cholesterol-lowering drugs called statins may have a lower risk of having another stroke, especially ischemic stroke, compared to people who also had an intracerebral hemorrhage but were not taking statins, according to a new study published in the August 30, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

30 Aug 2023

New mechanism of action discovered for pulmonary distress in immunocompromised patients

When an immunocompromised person's system begins to recover and produce more white blood cells, it's usually a good thing – unless they develop a potentially deadly inflammatory condition.

30 Aug 2023

Processing speed influences memory rehabilitation outcomes in TBI patients

Scientists at Kessler Foundation reported results from a randomized controlled trial examining the influence of processing speed on treatment benefits of the Kessler Foundation modified Story Memory Technique (KF-mSMT) in individuals with moderate to severe traumatic brain injury (TBI).

25 Aug 2023

Researchers discover new biological mechanism to regenerate and repair myelin

A study led by Dr. Hyun Kyoung Lee, associate professor at Baylor College of Medicine and investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, has discovered a new biological mechanism to regenerate and repair myelin, a protective sheath that insulates neuronal fibers and plays a vital role in ensuring rapid and accurate neurotransmission.

24 Aug 2023

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

N-acetylglucosamine reduces multiple inflammation and neurodegeneration markers in MS patients

People who require specialized neurologic care most often travel long distances, study finds

“Inverse vaccine” shows promise to reverse autoimmune diseases without shutting down rest of the immune system

Scientists develop new method to detect key fat-filled particles in the brain

NIH grants support Kessler Foundation scientists to advance research on neglect dyslexia and autism

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Convincing evidence supports avoidance of cannabis during adolescence, pregnancy and while driving

People with traumatic brain injuries in earlier life may be at increased risk of late life cognitive decline

Could medicinal plants be the key to reversing cognitive decline?

AI-driven analysis of MRI scans could pave the way for improved multiple sclerosis treatment

Scientists reclassify 200 rare immune system disorders using network-based approach

When temps rise, so do medical risks. Should doctors and nurses talk more about heat?

Statins may lower risk of ischemic stroke after hemorrhagic stroke

New mechanism of action discovered for pulmonary distress in immunocompromised patients

Processing speed influences memory rehabilitation outcomes in TBI patients

Researchers discover new biological mechanism to regenerate and repair myelin

Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

Brain lesions associated with MS memory dysfunction connect to a memory circuit

41% of people with post-viral syndrome had evidence of SARS-CoV-2 exposure

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in